Director/PDMR Shareholding
March 10 2010 - 1:01AM
UK Regulatory
TIDMIMTK
RNS Number : 3365I
Imaginatik PLC
10 March 2010
10 March 2010
Imaginatik plc
("Imaginatik" or the "Company")
Directors' Shareholding
Imaginatik plc (AIM: IMTK), a provider of collaborative innovation software and
processes, announces that it was notified yesterday that on the same day, Matt
Cooper, Non-Executive Chairman of the Company, purchased 1 million ordinary
shares of 0.0625 pence each in the Company ("Ordinary Shares") from Mark
Turrell, Chief Executive Officer of the Company, at a price of 4 pence per
Ordinary Share.
Following this transaction, Mr Turrell's beneficial interest in the Company
(including the Ordinary Shares of his wife, Dr Yvonne Lindow) is 76,819,415
Ordinary Shares, representing 48.25 per cent. of the issued share capital of the
Company, and Mr Cooper's holding is 1,478, 588 Ordinary Shares, representing
0.92 per cent. of the issued share capital of the Company.
Matt Cooper, Chairman of Imaginatik plc commented, "Imaginatik has proven its
ability to solve problems for some of the world's largest companies, harnessing
the brain power of their thousands of employees in a manner previously
impossible without the use of sophisticated technology. Having been in this
space for over a decade, Imaginatik is a leader in its market and as the
industry around it gains momentum, so its opportunity continues to grow."
For further information please contact:
+--------------------------------+----------------------------+
| Imaginatik plc | Tel: 020 7917 2975 |
+--------------------------------+----------------------------+
| Mark Turrell, CEO / Shawn | |
| Taylor, CFO | |
+--------------------------------+----------------------------+
| | |
+--------------------------------+----------------------------+
| Arbuthnot Securities Limited | Tel: 020 7012 2000 |
+--------------------------------+----------------------------+
| Tom Griffiths | |
+--------------------------------+----------------------------+
| | |
+--------------------------------+----------------------------+
| ICIS | Tel: 020 7651 8688 |
+--------------------------------+----------------------------+
| Caroline Evans-Jones / Hilary | |
| Millar | |
+--------------------------------+----------------------------+
About Imaginatik
Imaginatik is a leading provider of Collective Intelligence solutions, including
Collaborative Innovation, Open Innovation and Idea Management technology and
services. Some of the world's leading companies use Imaginatik's Idea Central
software platform to identify and develop the important ideas and strategies
that will drive the future of their business. For more than 10 years,
Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill
achieve outstanding results with the experience of its consulting team and
highly configurable web-based software.
Imaginatik is a public company whose shares are traded on the AIM market of the
London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer
with offices in Boston, MA, and London, UK. In 2009, Imaginatik was named as one
of the 500 fastest growing technology companies in the EMEA region by Deloitte.
Imaginatik is committed to ongoing research into the nature of human networks,
innovation and collective intelligence. The Company collaborates with several
academic institutions including the IXL Center at Hult International Business
School.
For further information please visit http://www.imaginatik.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSJLMLTMBIMBLM
Abal (LSE:ABAL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Abal (LSE:ABAL)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Abal Group Plc (London Stock Exchange): 0 recent articles
More Imaginatik News Articles